GlassScriptPhysician profile
Cory B Maughan
NPI 1598086720
$2,367.89
in general payments reported to CMS, 2019-2025
23 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.82 · 2020: $215 · 2021: $637 · 2022: $382 · 2023: $277 · 2024: $676 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $420.84 | 2021-2025 | Libtayo, Dupixent |
| Revance Therapeutics, INC. | $368.65 | 2024 | Daxxify |
| Prugen, INC. Pharmaceuticals | $355.00 | 2020-2021 | |
| Abbvie INC. | $286.59 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $145.07 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $125.88 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $116.33 | 2020-2024 | |
| Genzyme Corporation | $114.47 | 2020-2025 | |
| Galderma Laboratories, L.P. | $90.92 | 2020-2024 | |
| Vyne Pharmaceuticals INC. | $53.00 | 2021 | |
| Dermavant Sciences, INC. | $47.25 | 2024 | Vtama |
| Amgen INC. | $43.83 | 2022-2023 | Otezla |
| Janssen Biotech, INC. | $41.69 | 2024 | Tremfya, Simponi, Simponi Aria |
| Organogenesis INC. | $31.36 | 2022-2023 | Puraply |
| Medline Industries LP | $20.76 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $18.43 | 2023 | Cimzia |
| Leo Pharma INC. | $17.55 | 2023 | Adbry |
| Merz North America, INC. | $15.11 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.61 | 2022 | |
| Allergan, INC. | $14.05 | 2022 | |
| Incyte Corporation | $12.07 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.06 | 2019 | |
| Organon LLC | $2.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Maughan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.